"Syracuse Doctor's Breakthrough Against Deadly RSV Saves 3 Babies"

Three babies in Syracuse were the first in the world to receive a breakthrough RSV immunization as part of a clinical trial in 2015. The immunization, which has now been approved by the FDA, promises to reduce the chance of RSV hospitalization by 80%. RSV is the leading cause of hospitalizations for infants under 6 months old and claims the lives of over 100 infants each year in the United States. The new antibody is highly effective, more affordable, and provides longer-lasting protection compared to previous options. The success of the clinical trial in Syracuse has paved the way for this significant breakthrough in combating RSV.